Journal of Dual Diagnosis

Papers
(The TQCC of Journal of Dual Diagnosis is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use Substances19
Experiences Using Family or Peer Support for Smoking Cessation and Considerations for Support Interventions: A Qualitative Study in Persons With Mental Health Conditions18
Transdiagnostic Processes Linking Posttraumatic Stress Disorder Symptoms to Alcohol Use Severity16
Alcohol Use and Mental Health Symptoms in Nurses during the Early Months of COVID-1912
Highlights for the Journal of Dual Diagnosis from 202510
Spirituality/Religion Among First Responders With and Without Posttraumatic Stress Disorder and Alcohol Misuse10
Bipolar Disorder Hospitalizations and Substance Use Disorders: A Nationwide Retrospective Study From 2008 To 20159
Correction Notice9
Influence of Posttraumatic Stress Disorder on Daily-Level Trajectories of Opioid Use Among Trauma-Exposed Individuals in the Community Who Use Opioids9
Factors Associated With Increased Substance Use Disorder Care in VA PTSD Specialty Outpatient Treatment8
Implementing Chronic Care Model Treatments for Cigarette Dependence in Community Mental Health Clinics8
Posttraumatic Stress and Alcohol Use Among Hispanic/Latinx University Students: A Moderated Indirect Effect Model of Coping-Related Drinking and Anxiety Sensitivity8
Outcomes and Challenges of Motivational Interviewing in Dual Diagnosis Treatment—A Systematic Review7
Reduction of Psychosis Proneness in a Daycare Hospital Program for Patients with Severe Alcohol Use Disorder7
Pain Is Not a Predictor of Cannabis Use in People With Psychotic Disorders7
PTSD Symptom Severity and Alcohol Use among Firefighters: The Role of Emotion Regulation Difficulties7
Co-Occurring Posttraumatic Stress Disorder Symptoms and Alcohol Use Behaviors: The Mediating Role of Drinking to Cope with PTSD Symptoms7
Factors Associated with High-Risk Substance Use in Persons Receiving Psychiatric Treatment for a Primary Trauma- and Stressor-Related Disorder Diagnosis7
Drug-Free Community Support in Inpatients with Co-occurring Psychiatric Disorders and Substance Use Problems6
The Whys and Wherefores of Reducing Cannabis Use in Early Psychosis: A Qualitative Study of Service Users Experiences of Quitting and the Support6
“It’s Stable but Not Stable”: A Conceptual Framework of Subjective Housing Stability Definition Among Individuals with Co-occurring Mental Health and Substance Use Disorders6
Sleep and Rest-Activity Rhythms in Recovering Patients with Severe Concurrent Mental and Substance Use Disorder: A Pilot Study6
Psychostimulant Substitution Therapy for the Treatment of Stimulant Use Disorders in Patients with Schizophrenia or Schizoaffective Disorder: A Systematic Review6
Association of Lifetime Psychiatric Comorbidity and Current Substance Use in Methadone-Treated Individuals with Opioid Use Disorders5
Morbidity and Mortality Patterns Among Marginalized Individuals: Insights from a Copenhagen Shelter Health Clinic Cohort5
Introduction to Part 2 of the Special Issue on Trauma and Substance Misuse5
Posttraumatic Stress, Alcohol Use, and Alcohol Use Motives among Non-Hispanic Black/African American College Students: The Role of Emotion Regulation4
Trauma and Substance Misuse: Charting Heterogeneity in Comorbidity Dynamics, Vulnerable Populations, and Treatment Adaptation4
A Review of Digital Interventions to Decrease Cannabis Use Among Patients With Comorbid Psychiatric Disorders4
Cannabis Cessation, Inflammatory Markers and Schizophrenia4
A Qualitative Assessment of the Treatment Needs of Women with Concurrent Eating and Substance Use Disorders in a Residential Setting4
The Prevalence of Cannabis Use Disorder in Individuals with Anxiety or Related Disorders: A Systematic Review4
Substance Use Disorder and Anxiety, Depression, Eating Disorder, PTSD, and Phobia Comorbidities Among Individuals Attending Residential Substance Use Treatment Settings4
0.34060001373291